NAOV Financials: ENvue Medical, Inc. AI Analysis

Home

Stock

NAOV

Financials

NAOV Financial

ENvue Medical, Inc.

0%

$0

At close: Mar 25, 16:00:00 GMT-4

0%

$0

Pre-market: Mar 26, 10:21:41 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is NanoVibronix, Inc.?

NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The company is headquartered in Tyler, Texas and currently employs 15 full-time employees. The company went IPO on 2015-04-24. The firm focuses on two distinct technology platforms: Acoustic-based therapeutic technologies, including PainShield and UroShield, which utilize proprietary low-intensity surface acoustic wave (SAW) technology. These devices are intended for use in home or care settings and are designed to treat pain, reduce bacterial colonization, and disrupt biofilms. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters. The ENvue Navigation Platform, which is a minimally invasive electromagnetic navigation system intended to assist clinicians in placing feeding tubes into the gastrointestinal tract. ENvue provides real-time bedside visualization of tube movement and supports informed decision-making during the placement procedure.



Features

AI Copilot for Stock & Crypto

Resources

Market

Income

Balance sheet

Cash flow

Annual

Quarterly

NAOV Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	1,678	1,640	1,595	1,505	1,444	1,323
Revenue Growth (YoY)	1%	3%	6%	4%	9%	1%
Cost of Revenue	323	326	338	343	332	318
Gross Profit	1,355	1,313	1,256	1,161	1,112	1,005
Selling, General & Admin	756	737	690	663	618	545
Research & Development	331	315	335	318	260	230
Operating Expenses	1,191	1,174	1,163	1,136	1,052	964
Other Non Operating Income (Expenses)	-7	15	0	9	26	-26
Pretax Income	83	53	-77	-34	-75	-190
Income Tax Expense	73	43	48	19	24	-22
Net Income	10	9	-125	-53	-99	-167
Net Income Growth	-84%	-107%	136%	-46%	-41%	-9%
Shares Outstanding (Diluted)	314.51	313.49	288.58	281.1	250.4	273.7
Shares Change (YoY)	3%	9%	3%	12%	-9%	0%
EPS (Diluted)	0.03	0.03	-0.43	-0.19	-0.4	-0.61
EPS Growth	-85%	-107%	128%	-53%	-34%	-9%
Free Cash Flow	466	405	259	194	217	154
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	80.75%	80.06%	78.74%	77.14%	77%	75.96%
Operating Margin	9.71%	8.47%	5.83%	1.66%	4.15%	3.02%
Profit Margin	0.59%	0.54%	-7.83%	-3.52%	-6.85%	-12.62%
Free Cash Flow Margin	27.77%	24.69%	16.23%	12.89%	15.02%	11.64%
EBITDA	266	260	230	178	232	229
EBITDA Margin	15.85%	15.85%	14.42%	11.82%	16.06%	17.3%
D&A For EBITDA	103	121	137	153	172	189
EBIT	163	139	93	25	60	40
EBIT Margin	9.71%	8.47%	5.83%	1.66%	4.15%	3.02%
Effective Tax Rate	87.95%	81.13%	-62.33%	-55.88%	-32%	11.57%

Follow-Up Questions

What are ENvue Medical, Inc.'s key financial statements?



According to the latest financial statement (Form-10K), Informatica Inc has a total asset of $5,279, Net profit of $9

What are the key financial ratios for NAOV?



Informatica Inc's Current ratio is 1.77, has a Net margin is 0.54, sales per share of $5.23.

How is ENvue Medical, Inc.'s revenue broken down by segment or geography?



Informatica Inc largest revenue segment is Total Cloud and Subscription Support, at a revenue of 433,001,000 in the most earnings release.For geography, North America is the primary market for Informatica Inc, at a revenue of 1,097,088,000.

Is ENvue Medical, Inc. profitable?



yes, according to the latest financial statements, Informatica Inc has a net profit of $9

Does ENvue Medical, Inc. have any liabilities?



yes, Informatica Inc has liability of 2,972

How many outstanding shares for ENvue Medical, Inc.?



Informatica Inc has a total outstanding shares of 347.58

ENvue Medical, Inc. (NAOV) Financial

NAOV Stock Price Chart